Our study demonstrates that wogonin inhibits the proliferation of Pancreatic cancer cells both in vivo and invitro. Through bioinformatics analysis and experimental verification, the mechanism of wogonin sensitizing gemcitabine in pancreatic cancer may be through inhibition of Akt pathway. The gene discussed is AKT1; the disease is pancreatic neoplasm.